Guardant Health
GH
#3337
Rank
โ‚น298.25 B
Marketcap
โ‚น2,414
Share price
0.07%
Change (1 day)
28.82%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: โ‚น298.25 Billion

As of November 2024 Guardant Health has a market cap of โ‚น298.25 Billion. This makes Guardant Health the world's 3337th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น298.25 B9.12%
2023โ‚น273.33 B18.55%
2022โ‚น230.56 B-69.53%
2021โ‚น756.79 B-19.69%
2020โ‚น942.29 B80.08%
2019โ‚น523.26 B132.16%
2018โ‚น225.39 B

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Guardant Health was reported to be:

โ‚น298.25 Billion
by Yahoo Finance info icon info icon
โ‚น298.25 Billion
by CompaniesMarketCap info icon info icon
โ‚น298.25 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น1.399 T 369.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น296.74 B-0.51%๐Ÿ‡บ๐Ÿ‡ธ USA